These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12678790)

  • 1. Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?
    Dowsland MH; Harvey JR; Lennard TW; Kirby JA; Ali S
    Curr Med Chem; 2003 Apr; 10(7):579-92. PubMed ID: 12678790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines: novel targets for breast cancer metastasis.
    Ali S; Lazennec G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and chemokine receptors: A new strategy for breast cancer therapy.
    Liu H; Yang Z; Lu W; Chen Z; Chen L; Han S; Wu X; Cai T; Cai Y
    Cancer Med; 2020 Jun; 9(11):3786-3799. PubMed ID: 32253815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
    Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
    Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine networks and breast cancer metastasis.
    Karnoub AE; Weinberg RA
    Breast Dis; 2006-2007; 26():75-85. PubMed ID: 17473367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines, chemokine receptors, and cancer metastasis.
    Kakinuma T; Hwang ST
    J Leukoc Biol; 2006 Apr; 79(4):639-51. PubMed ID: 16478915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemokines in breast cancer pathology and its possible use as therapeutic targets.
    Palacios-Arreola MI; Nava-Castro KE; Castro JI; García-Zepeda E; Carrero JC; Morales-Montor J
    J Immunol Res; 2014; 2014():849720. PubMed ID: 25165728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines: agents for the immunotherapy of cancer?
    Homey B; Müller A; Zlotnik A
    Nat Rev Immunol; 2002 Mar; 2(3):175-84. PubMed ID: 11913068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
    Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
    Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological relevance of chemokine-proteoglycan interactions.
    Proudfoot AE
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):422-6. PubMed ID: 16709177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
    Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeostatic chemokine receptors and organ-specific metastasis.
    Zlotnik A; Burkhardt AM; Homey B
    Nat Rev Immunol; 2011 Aug; 11(9):597-606. PubMed ID: 21866172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
    Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
    Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and their role in tumor growth and metastasis.
    Wang JM; Deng X; Gong W; Su S
    J Immunol Methods; 1998 Nov; 220(1-2):1-17. PubMed ID: 9839921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the discovery and development of therapies for metastatic breast cancer.
    Eckhardt BL; Francis PA; Parker BS; Anderson RL
    Nat Rev Drug Discov; 2012 Jun; 11(6):479-97. PubMed ID: 22653217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in second-line therapies for metastatic breast cancer].
    Shigekawa T; Osaki A; Saeki T
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):408-15. PubMed ID: 25963688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.